These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 36559175)

  • 1. Recent Advances in Lipid Nanoparticles for Delivery of mRNA.
    Yang L; Gong L; Wang P; Zhao X; Zhao F; Zhang Z; Li Y; Huang W
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy.
    Soroudi S; Jaafari MR; Arabi L
    J Control Release; 2024 Aug; 372():113-140. PubMed ID: 38876358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
    Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
    Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles.
    Ross-Thriepland D; Bornot A; Butler L; Desai A; Jaiswal H; Peel S; Hunter MR; Odunze U; Isherwood B; Gianni D
    SLAS Discov; 2020 Jul; 25(6):605-617. PubMed ID: 32441189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Delivery of mRNA for Cell-Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles.
    Ma T; Chen X; Wang M
    Chembiochem; 2023 May; 24(9):e202200801. PubMed ID: 36780174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery.
    Swingle KL; Billingsley MM; Bose SK; White B; Palanki R; Dave A; Patel SK; Gong N; Hamilton AG; Alameh MG; Weissman D; Peranteau WH; Mitchell MJ
    J Control Release; 2022 Jan; 341():616-633. PubMed ID: 34742747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building a Better Silver Bullet: Current Status and Perspectives of Non-Viral Vectors for mRNA Vaccines.
    Gu J; Xu Z; Liu Q; Tang S; Zhang W; Xie S; Chen X; Chen J; Yong KT; Yang C; Xu G
    Adv Healthc Mater; 2024 Jan; 13(3):e2302409. PubMed ID: 37964681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA delivery technologies: Toward clinical translation.
    Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
    Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
    Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
    AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies.
    Huang X; Ma Y; Ma G; Xia Y
    Research (Wash D C); 2024; 7():0370. PubMed ID: 38894715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions.
    Nawaz M; Heydarkhan-Hagvall S; Tangruksa B; González-King Garibotti H; Jing Y; Maugeri M; Kohl F; Hultin L; Reyahi A; Camponeschi A; Kull B; Christoffersson J; Grimsholm O; Jennbacken K; Sundqvist M; Wiseman J; Bidar AW; Lindfors L; Synnergren J; Valadi H
    Adv Sci (Weinh); 2023 Apr; 10(12):e2206187. PubMed ID: 36806740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
    Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB
    Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
    Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M
    J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of
    Jung HN; Lee SY; Lee S; Youn H; Im HJ
    Theranostics; 2022; 12(17):7509-7531. PubMed ID: 36438494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity.
    Wu L; Li X; Qian X; Wang S; Liu J; Yan J
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
    Tenchov R; Bird R; Curtze AE; Zhou Q
    ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs.
    Li Y; Ye Z; Yang H; Xu Q
    Acta Pharm Sin B; 2022 Jun; 12(6):2624-2639. PubMed ID: 35755280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.